TipRanks
Banka BioLoo Ltd. (IN:BANKA)
:BANKA
India Market
Want to see IN:BANKA full AI Analyst Report?

Banka BioLoo Ltd. (BANKA) AI Stock Analysis

1 Followers

Top Page

IN:BANKA

Banka BioLoo Ltd.

(BANKA)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - Gpt-5.6Sol)
Rating:41Neutral
Price Target:
₹65.00
▼(-17.93% Downside)
Action:Reiterated
Date:08/28/26
The score is held back primarily by weak financial quality—especially persistently negative operating/free cash flow alongside higher leverage and volatile profitability. Technicals also lean bearish in the near term with the stock trading below key moving averages and negative MACD. Valuation is an additional drag due to the extremely high P/E, which amplifies risk given the company’s inconsistent earnings and cash generation.
Positive Factors
Specialized sanitation business model
The company addresses sanitation needs through portable or semi-permanent units plus collection and servicing. This integrated offering can remain relevant across locations lacking conventional sewer infrastructure, supporting a focused operating model and repeat service activity.
Negative Factors
Persistently negative cash generation
Repeatedly negative operating and free cash flow shows that reported business activity is not consistently converting into internal liquidity. Continued cash absorption can increase reliance on external funding, constrain investment flexibility, and make the company more vulnerable when profitability weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized sanitation business model
The company addresses sanitation needs through portable or semi-permanent units plus collection and servicing. This integrated offering can remain relevant across locations lacking conventional sewer infrastructure, supporting a focused operating model and repeat service activity.
Read all positive factors

Banka BioLoo Ltd. (BANKA) vs. iShares MSCI India ETF (INDA)

Banka BioLoo Ltd. Business Overview & Revenue Model

Company Description
Banka BioLoo Limited is an Indian enterprise offering a comprehensive suite of products and services for sanitation and waste management. A key aspect of its operations involves the design, provision, and deployment of bio-toilets. Beyond installa...

Banka BioLoo Ltd. Financial Statement Overview

Summary
Revenue has grown over multiple years, but profitability has been volatile (sharp loss in FY2025, only a small profit in FY2026). Leverage has risen materially (debt-to-equity above 1.0x in FY2025–FY2026). Most importantly, operating and free cash flow have been persistently negative in recent years, indicating ongoing cash absorption and higher funding risk.
Income Statement
46
Neutral
Balance Sheet
52
Neutral
Cash Flow
28
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue565.03M570.92M541.74M499.96M423.50M387.51M
Gross Profit162.46M58.70M9.87M337.57M368.11M320.30M
EBITDA65.32M62.25M-28.60M41.85M66.06M58.91M
Net Income3.57M3.93M-89.09M-6.53M25.39M31.08M
Balance Sheet
Total Assets0.001.01B821.55M774.23M652.07M640.54M
Cash, Cash Equivalents and Short-Term Investments110.08M110.08M40.70M16.88M13.41M8.29M
Total Debt0.00408.03M347.28M259.13M167.15M184.96M
Total Liabilities-425.75M581.35M505.70M376.61M251.09M265.52M
Stockholders Equity425.75M395.55M315.13M397.20M400.99M375.02M
Cash Flow
Free Cash Flow11.47M-82.89M-69.53M-72.06M9.40M-36.00M
Operating Cash Flow42.83M-22.92M-24.71M27.63M73.53M-4.40M
Investing Cash Flow-5.01M-24.17M-63.44M-100.69M-57.18M-27.17M
Financing Cash Flow-39.54M146.75M87.50M67.76M-33.29M9.55M

Banka BioLoo Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price79.20
Price Trends
50DMA
80.77
Negative
100DMA
84.90
Negative
200DMA
73.90
Negative
Market Momentum
MACD
-2.79
Positive
RSI
30.91
Neutral
STOCH
2.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Negative. The current price of 79.2 is above the 20-day moving average (MA) of 76.44, below the 50-day MA of 80.77, and above the 200-day MA of 73.90, indicating a bearish trend. The MACD of -2.79 indicates Positive momentum. The RSI at 30.91 is Neutral, neither overbought nor oversold. The STOCH value of 2.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BANKA.

Banka BioLoo Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
₹1.58B10.49――2.73%-18.79%
56
Neutral
₹59.62B48.99―0.31%10.15%-53.64%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
46
Neutral
₹758.83M4.29――-9.15%-26.97%
41
Neutral
₹748.95M221.13―0.95%7.77%―
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BANKA
Banka BioLoo Ltd.
68.51
-21.07
-23.52%
IN:BEWLTD
BEW Engineering Ltd.
58.50
-85.50
-59.38%
IN:DUCON
Ducon Infratechnologies Ltd.
1.32
-2.35
-64.08%
IN:IONEXCHANG
Ion Exchange (India) Ltd.
406.50
4.16
1.03%
IN:KHFM
KHFM Hospitality & Facility Management Services Ltd.
41.95
-29.60
-41.37%
IN:TEXMOPIPES
Texmo Pipes & Products Ltd.
54.13
-1.27
-2.29%

Banka BioLoo Ltd. Corporate Events

Banka BioLoo Holds 14th AGM Via Video Conferencing, Plans Prompt Disclosure of Voting Results
Sep 17, 2026
Banka BioLoo Ltd. convened its 14th Annual General Meeting on September 17, 2026, via video conferencing and other audio-visual means, with the session deemed to be held at its corporate office in Hyderabad. The meeting brought together key member...
Banka BioLoo Sets Virtual Date for 14th Annual General Meeting
Aug 21, 2026
Banka BioLoo Ltd. has notified the National Stock Exchange of India that its 14th Annual General Meeting will be held on 17 September 2026 at 3:00 p.m. via video conferencing and other audio-visual means. The company has published newspaper advert...
Banka BioLoo Publishes Q1 FY27 Unaudited Results in Line With SEBI Norms
Aug 15, 2026
Banka BioLoo has published its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 in the Financial Express (English) and Nava Telangana (Telugu), in line with Indian securities listing regulations. The compa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 28, 2026